No Surprises


Scharf Investments' Brian Krawez and Loren Kinczel explain the two key metrics on which they focus to limit downside, the primary reason they walk away from demonstrably cheap stocks, when they'll override their screens to buy something, and why they believe Advance Auto Parts, Novartis, Life Technologies and Lockheed Martin are mispriced.

If you are a subscriber, log in to access the issue and bonus archive: